Company profile
Bot Verification
Glyconics Limited is a UK company with status active founded in 2013 based in East of England.
Financial period: 1 Oct 2024 to 31 Mar 2025
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
SH01 | Transaction MzQ1NjMzMzQ4NWFkaXF6a2N4
Published 25 Feb 2025 01:09
AA01 | Transaction MzQ0MTc3NTE5NWFkaXF6a2N4
Published 01 Nov 2024 04:54
AA | Transaction MzQ0MTc3MTc3NmFkaXF6a2N4
Published 01 Nov 2024 04:09
MR04 | Transaction MzQzMjAwNzQ0OWFkaXF6a2N4
Published 13 Aug 2024 16:19
Company registered at Companies House
1 Jul 2021 to 31 Dec 2022
The development of a Cloud-based real-time screening capability for the presence of the COVID-19 virus in nasopharyngeal swabs using Mid-InfraRed spectroscopy. A system designed around a high resolution fully portable device with internet connectivity.
1 Oct 2020 to 31 Mar 2021
Diabetes is a major global challenge for which the vast majority (\>90%) of cases have type-2 diabetes that is largely preventable/manageable through lifestyle interventions if caught early. Early detection is key to long-term management of the condition, enabling cost savings per patient and an increase in life-years. Existing portable diagnostic techniq...
1 Sep 2017 to 31 May 2018
Development of a Miniaturised Infra-red (IR) Spectrometer for Improved Diagnosis of Chronic Obstructive Pulmonary Disease (COPD) and Early Identification of Exacerbation.
1 Sep 2015 to 31 Mar 2017
Glyconics has developed a new device for rapid, cost-effective diagnosis of Chronic Obstructive Pulmonary Disease (COPD) using sputum samples. The technology analyses the presence of specific markers in sputum that are characteristic of COPD. In addition the technology is able to detect the onset of an exacerbation episode earlier than the current methods...
